A quantitative overview of radiosensitivity of human tumor cells across histological type and TP53 status

International Journal of Radiation Biology

Volumn 84, Issue 4, 2008, Pages 253-264

  Williams, Jerry R ^a,b   Zhang, Yonggang ^b   Zhou, Haoming ^b   Gridley, Daila S ^a   Koch, Cameron J ^c   Russell, James ^d   Slater, James S ^a   Little, John B ^e  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

ATM; Human tumor cells; Radiosensitivity; TP53

Indexed keywords

14 3 3SIGMA GENE; ARTICLE; ATM GENE; BLADDER TUMOR; BREAST TUMOR; CDKN1A GENE; CELL SURVIVAL; COLORECTAL TUMOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MISMATCH REPAIR GENE; GENE; GENE EXPRESSION PROFILING; GENOTYPE; GLIOBLASTOMA; HUMAN; HUMAN CELL; LIVER TUMOR; MELANOMA; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROSTATE TUMOR; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIOSENSITIVITY; SURVIVAL RATE; TERATOMA; TP53 GENE; TUMOR CELL; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; RADIATION DOSAGE; RADIATION TOLERANCE; TUMOR SUPPRESSOR PROTEIN P53;

ATAXIA TELANGIECTASIA;

EID: 41749102683     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000801953342     Document Type: Article

References (29)

1. Allison SG, Milner J. 2004. Remodelling chromatin on a global scale: A novel protective effect of p53. Carcinogenesis 25(9):1551-1557.
2. Banath J, MacPhail S, Olive P. 2004. Radiation sensitivity, H2AX phosphorylation and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Research 64:7144-7149.
3. Bunz F, Hwang PM, Torrance C, Waldmann T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler K, Vogelstein B. 1999. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. Journal of Clinical Investigations 104:263-269.
4. Bristow RG, Benchimol S, Hill RP. 1996. The p53 gene as a modifier of intrinsic radiosensitivity: Implications for radiotherapy. Radiotherapy and Oncology 40:197-223.
5. Chapman JD. 2003. Single hit mechanisms of tumour cell killing by radiation. International Journal of Radiation Biology 79(2):71-81.
6. Chan TA, Hermeking H, Lengauer C. 1991. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature 401:616-620 (1999).
7. Chan TA, Hermeking H, Langauer C, Kinzler KW, Vogelstein B. 1999. 1-3-3 Sigma is required to prevent metabolic catastrophe after DNA damage. Nature 7(6753):616-620.
8. Chiarugi V, Magnelli L, Cinelli M. 1998. Role of p53 mutations in the radiosensitivity status of tumor cells. Tumori 84(5):517-520.
9. Dahm-Daphi J. 2000. p53: Biology and role for cellular radiosensitivity. Strahlentherapie und Onkologie 176:278-285.
10. Fertil B, Dertinger H, Courdi A, Malaise EP. 1984. Mean Inactivation Dose: A useful concept for intercomparison of human cell survival curves. Radiation Research 19(1):73-84.
11. Fertil B, Dertinger H, Courdi A, Malaise EP. 1985. Mean Inactive dose for intercomparison of human cell survival curves. Radiation Research 99(1):73-84.
12. Fertil B, Malaise EP. 1985. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: Analysis of 101 published survival curves. International Journal of Radiation, Oncology, Biology, and Physics 11(9):1699-1707.
13. Fowler JF. 1983. Dose-response curves for organ function in cell survival. British Journal of Radiology 56:497-500.
14. Kastan MB, Onyekwere O, Sidransky D. 1991. Participation of p53 protein in cellular response to DNA damage. Cancer Research 51:6304-6311.
15. Koi M, Umar A, Chauhan DP. 1994. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Research 54:4308-4312.
16. Malaise EP, Fertil B, Chavaudra N, Guichard M. 1986. Distribution of radiation sensitivities for human tumor cells of specific histological types: Comparison of in vitro to in vivo data. International Journal of Radiation, Oncology, Biology, and Physics 12(4):617-624.
17. Matsui Y, Tscuchida Y, Keng PC. 2001. Effects of p53 mutations on cellular sensitivity to ionizing radiation. American Journal of Clinical Oncology 24(5):486-490.
18. Puck TT, Markus PI. 1956. Action of X-rays on mammalian cells. Journal of Experimental Medicine 103:653-666.
19. Robles AI, Linke SP, Harris CC. 2002. The p53 network in lung carcinogenesis. Oncogene 21:6898-6907.
20. Servomaa K, Kiuru A, Grenman R, Pekkola-Heino K, Pulkkinen JO, Rytomaa T. 1996. p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines. Cellular Proliferation 29(5):219-230.
21. Sklar MD. 1998. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 239:645-647.
22. Tubiana M, Dutreix J, Pierquin B. 2006. A century of radiotherapy. International Journal of Radiation, Oncology, Biology, and Physics 35(2):227-242.
23. Thames HD Jr, Withers HR, Peters LJ, Fletcher GH. 1982. Changes in early and late radiation responses with altered dose fractionation: Impliations for dose-survival relationships. International Journal of Radiation, Oncology, Biology, and Physics 8:219-226.
24. Tribius S, Pidel A, Casper D. 2001. ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture. International Journal of Radiation, Oncology, Biology, and Physics 50:511-523.
25. Waldman T, Zhang Y, Dillehay LE, Yu J, Kinzler K, Vogelstein B, Williams J. 1997. Cell cycle arrest vs. cell death in cancer therapy. Nature Medicine 3:1034-1036.
26. Weber KJ, Wenz F. 2002. p53, apoptosis and radiosensitivity-experimental and clinical data. Onkologie 25:136-141.
27. West CM, Davidson SE, Roberts SA, Hunter RD. 1997. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. British Journal of Cancer 76:1184-1190.
28. Williams JR, Zhang Y, Russell J, Koch C, Little JB. 2007a. Human tumor cells segregate into radiosensitivity groups that associate with ATM and TP53 status. Acta Oncologica 46(5):628-638.
29. Williams JR, Zhang Y, Zhou H, Russell J, Gridley DS, Koch CJ, Little JB. 2007b. Genotype-dependent radiosensitivity: Clonogenic survival, apoptosis and cell-cycle redistribution. International Journal of Radiation Biology 84(2):1-13.